7-OH Testing Available

Expanding Our Definitive Testing Menu: Adding 7-Hydroxymitragynine (7-OH) via LC-MS/MS

As the market for novel psychoactive substances and high-potency botanical extracts continues to evolve, clinical and forensic laboratories must stay ahead of emerging detection challenges. We are pleased to announce the addition of 7-hydroxymitragynine (7-OH) to our definitive toxicology testing menu.

Why 7-OH Testing Matters

While mitragynine has long been monitored as the primary alkaloid in kratom (Mitragyna speciosa*), 7-hydroxymitragynine (7-OH) is significantly more potent at central mu-opioid receptors. With the rapid rise of concentrated 7-OH tablets, shots, and synthetic extracts, standard immunoassay screening panels frequently miss active exposure or generate inconclusive results.

Key advantages of our LC-MS/MS assay include:

Definitive Specificity from our LC-MS/MS instruments prevents differentiates 7-OH from mitragynine, minor alkaloids, and co-eluting compounds.